Prestige Wealth Management Group’s Outlook Therapeutics OTLK Stock Holding History

Prestige Wealth Management Group’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13	Hold	62	–	–	﹤0.01%	1120
2025 Q4	$98	Hold	62	–	–	﹤0.01%	999
2025 Q3	$66	Hold	62	–	–	﹤0.01%	987
2025 Q2	$100	Hold	62	–	–	﹤0.01%	993
2025 Q1	$76	Hold	62	–	–	﹤0.01%	1003
2024 Q4	$118	Hold	62	–	–	﹤0.01%	1028
2024 Q3	$332	Hold	62	–	–	﹤0.01%	1002
2024 Q2	$458	Hold	62	–	–	﹤0.01%	937
2024 Q1	$741	Sell	62 -1	-2%	-$8	﹤0.01%	907
2023 Q4	$493	Hold	63	–	–	﹤0.01%	950
2023 Q3	$277	Hold	63	–	–	﹤0.01%	1014
2023 Q2	$2.17K	Hold	63	–	–	﹤0.01%	745
2023 Q1	$1.36K	Hold	63	–	–	﹤0.01%	830
2022 Q4	$1.35K	Hold	63	–	–	﹤0.01%	912
2022 Q3	$2K	Hold	63	–	–	﹤0.01%	762
2022 Q2	$1K	Hold	63	–	–	﹤0.01%	899
2022 Q1	$2K	Hold	63	–	–	﹤0.01%	793
2021 Q4	$2K	Hold	63	–	–	﹤0.01%	816
2021 Q3	$3K	Hold	63	–	–	﹤0.01%	747
2021 Q2	$3K	Hold	63	–	–	﹤0.01%	742
2021 Q1	$3K	Hold	63	–	–	﹤0.01%	732
2020 Q4	$2K	Hold	63	–	–	﹤0.01%	773
2020 Q3	$1K	Hold	63	–	–	﹤0.01%	818
2020 Q2	$2K	Hold	63	–	–	﹤0.01%	685
2020 Q1	$1K	Hold	63	–	–	﹤0.01%	812
2019 Q4	$1K	Hold	63	–	–	﹤0.01%	545
2019 Q3	$2K	Hold	63	–	–	﹤0.01%	502
2019 Q2	$3K	Hold	63	–	–	﹤0.01%	437
2019 Q1	$9K	Buy	+63	New	+$8.9K	0.01%	346

Other funds holding OTLK

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $126M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NMC

Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Prestige Wealth Management Group's OTLK Position: Q1 2026 in Review

Prestige Wealth Management Group held its Outlook Therapeutics (OTLK) position steady in Q1 2026 at 62 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

Prestige Wealth Management Group first reported a position in OTLK in Q1 2019 and has held it in 29 quarters since. The position peaked at $9K in Q1 2019. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

Prestige Wealth Management Group held 62 shares of Outlook Therapeutics worth $13 as of Q1 2026.
Prestige Wealth Management Group left its Outlook Therapeutics share count unchanged in Q1 2026.
Outlook Therapeutics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #1120 holding.
Prestige Wealth Management Group first reported a position in Outlook Therapeutics in Q1 2019 and has held it in 29 quarters since.
Prestige Wealth Management Group's Outlook Therapeutics position peaked at $9K in Q1 2019.
54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.